| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | GameSquare Holdings, Inc.: GameSquare's Stream Hatchet Recaps 2024's Biggest Live Streaming Trends in its Save Point 2024 Report | The Save Point 2024 report looks back at the year's newest live-streaming platforms, the most popular streamers, top games, new alternative content capturing viewer interest, and the new meta for esportsView... ► Artikel lesen | |
| Di | GameSquare brings SpongeBob SquarePants to Fortnite | ||
| Di | GameSquare Holdings, Inc.: GameSquare Announces Latest Fortnite UEFN Campaign with Nickelodeon's SpongeBob SquarePants | Launch Of Four Immersive UEFN Experiences Marks The Arrival Of Nickelodeon's SpongeBob SquarePants To The Fortnite PlatformWatch Trailer here FRISCO, TX / ACCESSWIRE / December 17, 2024 / Zoned, a GameSquare... ► Artikel lesen | |
| 21.11. | GameSquare Holdings, Inc.: GameSquare's Stream Hatchet Publishes Q3 Report | Live Streaming Insights Show Major Growth in Gaming Content EngagementNew Report Reveals Today's Top CreatorsView the report: https://streamhatchet.com/q3-2024-live-streaming-trend-report/ FRISCO, TX... ► Artikel lesen | |
| 15.11. | GameSquare Holdings, Inc. - 8-K, Current Report |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Outlook Therapeutics, Inc. - 8-K, Current Report | ||
| 13.12. | Outlook Therapeutics, Inc.: Outlook Therapeutics Streamlines Operations | ISELIN, N.J., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United Kingdom... ► Artikel lesen | |
| 04.12. | Outlook Therapeutics, Inc.: Outlook Therapeutics Announces NICE Recommendation of LYTENAVA (bevacizumab gamma) for the Treatment of Wet AMD | First positive reimbursement decision worldwide for LYTENAVA; First launch anticipated in H1 2025
LYTENAVA is the first and only approved ophthalmic formulation of bevacizumab for the treatment... ► Artikel lesen | |
| 03.12. | Outlook Therapeutics announces CEO resignation | ||
| 03.12. | Outlook Therapeutics ernennt Interims-CEO und plant Produkteinführung |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.03. | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 14.03.2024 | The following instruments on XETRA do have their first trading 14.03.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 14.03.2024
Aktien
1 IT0005585093 Juventus Football Club... ► Artikel lesen | |
| 13.03. | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen CA3649341094 GameSquare Holdings Inc. 13.03.2024 US36468G1031 GameSquare Holdings Inc. 14.03.2024 Tausch 1:1 US69012T2069 Outlook... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| GAMESQUARE HOLDINGS INC | 0,781 | -4,77 % |
| OUTLOOK THERAPEUTICS INC | 1,390 | +0,72 % |
| VAXXA AB | 0,089 | -4,84 % |
